Latest News & Updates

Biologics Contribute to Growth in Pharma Products Cold-Chain Market

In its September issue, Pharmaceutical Commerce details the previous and expected contributions of biologic products to its forecast of cold-chain market growth predicting sales of cold-chain drugs and biologics will outpace overall industry growth through 2022. It is reported that “as of 2018, global...

Wednesday, September 12, 2018 | Read More

FDA Researchers Explore Fundamental Chemical Reaction that Could Threaten the Quality of Therapeutic Protein Products

In a recent news release the FDA described research it has conducted regarding detection of protein carbonylation, an oxidative reaction that may occur in therapeutic protein drug products during manufacture, storage, use, and transport potentially causing structural alterations and threatening stability,...

Tuesday, September 11, 2018 | Read More

Sentry representatives attend DCAT week

Sentry BioPharma Services is pleased to announce delegates from Sentry’s Business Development team will be in New York City attending the Drug, Chemical & Associated Technologies Association (DCAT) Week March 19th -22nd. The four-day conference brings together key sourcing, procurement and business...

Monday, March 19, 2018 | Read More

API Management

API Management: Sophisticated Oversight for High-Value Ingredients

Active pharmaceutical ingredients (APIs) and high-risk biopharmaceutical products share at least one attribute: the probability and impact of loss is manageable. Sentry BioPharma Services applies the same principles implemented across high-risk and high-value products to the management and protection of high-value APIs. Sentry’s experienced team strives to limit the probability and impact of loss, providing unparalleled protection for high-value ingredients. Safeguarding expertise translates into redundant systems to maintain temperature profile, electronic and/or physical product segregation and custom client operating procedures.

Sentry's API management capabilities include:

Whether supporting manufacturing, analysis, or storage, Sentry adheres to standard operating procedures (SOPs) and good manufacturing practices (GMPs) throughout storage and handling.

For more information about how Sentry can assist with high-potency, high-value and high-risk products and materials, contact Sentry via email or by phone at 1-866-757-7400.